Market closed

Fortrea Holdings/$FTRE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Fortrea Holdings

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Ticker

$FTRE
Trading on

Industry

Life Sciences Tools & Services

Employees

15,500

Fortrea Holdings Metrics

BasicAdvanced
$2B
Market cap
-
P/E ratio
-$3.36
EPS
-
Beta
-
Dividend rate
$2B
$41.02
$16.53
1.4M
1.177
0.998
78.619
79.544
-0.49%
-1.04%
-13.59%
0.658
1.3
-2.08
8.707
2.80%
-581.17%

What the Analysts think about Fortrea Holdings

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Fortrea Holdings stock.

Fortrea Holdings Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Fortrea Holdings Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $FTRE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Fortrea Holdings stock?

Fortrea Holdings (FTRE) has a market cap of $2B as of November 14, 2024.

What is the P/E ratio for Fortrea Holdings stock?

The price to earnings (P/E) ratio for Fortrea Holdings (FTRE) stock is 0 as of November 14, 2024.

Does Fortrea Holdings stock pay dividends?

No, Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders as of November 14, 2024.

When is the next Fortrea Holdings dividend payment date?

Fortrea Holdings (FTRE) stock does not pay dividends to its shareholders.

What is the beta indicator for Fortrea Holdings?

Fortrea Holdings (FTRE) does not currently have a Beta indicator.